For Consumers
Consumer Updates: Vaccines, Blood & Biologics
Consumer Updates are timely articles that cover product approvals, safety warnings, and other health information for you and your family. You can sign up to receive e-mail alerts about new articles immediately after they are posted on FDA's Web site, or on a daily, weekly, or monthly basis. You can also sign up for an RSS feed. Some of these articles are available in Spanish.
Consumer Updates related to biologics are featured on this page. Biologics are medical products derived from living sources. They include vaccines, blood and blood derivatives, allergenic patch tests and extracts, tests to detect HIV and hepatitis, gene therapy products, cells and tissues for transplantation, and new treatments for cancers, arthritis, and other serious diseases. FDA's Center for Biologics Evaluation and Research (CBER) regulates a wide range of biological products. The agency's Center for Drug Evaluation and Research (CDER) also regulates certain categories of biological products.
Biologics
- FDA Teams with Everyday Health to Expand Reach of Health Information
- FDA's MedWatch Safety Alerts: October 2009
- FDA's International Posts: Improving the Safety of Imported Food and Medical Products
- FDA's MedWatch Safety Alerts: September 2009
- FDA 101: Product Recalls (video)
- Vaccines Approved for H1N1 Influenza Virus
- A Parent's Guide to Kids' Vaccines
- FDA Promotes Openness and Transparency to Public
- La FDA promueve la apertura y la transparencia hacia el público
- H1N1 Flu: FDA Responds Quickly to Protect the Public's Health
- Itching for Allergy Relief?
- FDA 101: Clinical Trials and Institutional Review Boards
- Your Guide to Reporting Problems to FDA
- Should Your Child Be in a Clinical Trial?
- FDA 101: How to Use the Consumer Complaint System and MedWatch
- FDA and WebMD Form Partnership
- FDA 101: Product Recalls - From First Alert to Effectiveness Checks
- Is It Really FDA Approved?
- Strengthening the Advisory Committee Process
- New Steps to Improve Advisory Committee Processes
- FDA 101: Advisory Committees
- FDA 101: Regulating Biological Products
- FDA's Strategic Plan: Charting Our Course for the Future
- Una guía para los padres sobre las vacunas de los hijos
- Human Gene Therapies: Novel Product Development Q&A with Celia M. Witten, Ph.D, M.D.
- Have You Given Blood Lately?
- Nasal Influenza Vaccine Approved for Younger Children
- The Critical Path: Making Medical Products Better, Faster, and Cheaper
- Building a Stronger Defense Against Bioterrorism
- FDA Releases Statement on Gene Therapy Trial